Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

SAB Biotherapeutics (SABS) Debt Ratio: 2020-2022

  • SAB Biotherapeutics' Debt Ratio was N/A to 0.01 in Q4 2022 from the same period last year, while for Dec 2022 it was 0.01, marking a year-over-year change of. This contributed to the annual value of 0.01 for FY2022, which is N/A change from last year.
  • Latest data reveals that SAB Biotherapeutics reported Debt Ratio of 0.01 as of Q4 2022, which was up 249.68% from 0.00 recorded in Q4 2020.
  • SAB Biotherapeutics' 5-year Debt Ratio high stood at 0.01 for Q4 2022, and its period low was 0.00 during Q4 2020.
  • Over the past 2 years, SAB Biotherapeutics' median Debt Ratio value was 0.01 (recorded in 2020), while the average stood at 0.01.